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Hooray!
New Rule Now In Effect
H
ello,  everyone.  It’s  official: 
  Effective July 20, individuals with 
a special issuance are no longer required 
to have their authorization letter with 
them while aviating. I realize that I 
informed you about this change in my 
last editorial, but this is such a significant 
change that I think it bears repeating. 
The  news  may  not  amount  to  a 
hill of beans to many of the pilots you 
examine simply because most of them 
meet Federal Aviation Administration 
medical standards and do not require a 
special issuance (waiver). In fact, many 
of them may not even be aware that 
there are such letters, but they probably 
will be affected by this change as they 
get older and might require a special 
issuance of their own. 
The requirement to carry the letter 
stemmed from an audit of the FAA by 
the International Civil Aviation Author-
ity (ICAO) that took place in 2007. At 
that time, the auditor, without consult-
ing the ICAO Medical Officer, insisted 
that  ICAO  International  Standards 
and Recommended Practices (SARPS) 
required that we include all disqualify-
ing medical conditions on an applicant’s 
medical certificate. 
While we vigorously pushed back, 
we  could  not  convince  the  auditor 
that he was wrong. However, we were 
finally able to get him to agree that the 
disqualifying information was contained 
in the authorization letter, and that we 
could meet the intent of the SARPS by 
requiring the individual to carry the 
letter while flying. 
Shortly after we announced the re-
quirement to carry the letter, we began 
to get complaints from airmen and avia-
tion organizations that the obligation to 
show it to inspectors was an unnecessary 
violation of the airman’s privacy. We 
agreed with them and so did the ICAO 
Medical Officer, and he helped us get 
the ruling reversed. While it has taken 
a long time, we are finally there, but we 
still have a couple of issues to deal with.
The  paper  medical  certificates 
and the computerized MedXPress 
certificates have a note on the back 
that says: “A letter of authorization 
(or  SODA)  describing  any  such 
limitations must be kept with this 
certificate at all times while exer-
cising the privileges of an airman 
certificate.” 
We  are  working  on  the  program-
ming  changes  necessary  to  modify 
MedXPress, but we cannot modify the 
paper forms because it would not be 
cost effective to do so before October 1. 
We also do not plan to issue replace-
ment certificates to everyone who has 
been issued a certificate with the obsolete 
language. So, for some time, individuals 
will be carrying certificates with the 
outdated language on the back. 
I also want to make it clear that even 
though the entire note will go away, air-
men with a SODA will still be required 
to have their SODA with them when 
they fly. 
You may be asking yourself, What can 
I do? You might be surprised to know 
that you interact with airmen more than 
anyone else in the FAA. So if any of the 
airmen you examine have special issu-
ances, please take a few extra minutes 
to explain these changes. 
If you have questions about this issue 
or any other issue, call your Regional 
Flight Surgeon. He or she is “up-to-
speed” on all of the latest information 
and  is  ready  to  help  so  that  we  can 
provide the best service to the airmen 
we support.
Thank you for your help with imple-
menting these changes, and as always, 
thank you for everything you do for the 
airmen you take care of.
Cheers!
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Glaucoma case report comments
Dear Editor,
The article…about Glaucoma [Case 
Report by Joseph A. Lopez, MD, Fed-
eral Air Surgeon’s Medical Bulletin, vol. 
50, no. 2, pg. 12] was informative and 
mostly correct. One glaring point that 
should be made is that the eye specialist 
should be an ophthalmologist. Not an 
optometrist. Optometrists may not have 
the training needed to properly evaluate 
a patient for the extent of glaucoma, 
usually needs supervision by an oph-
thalmologist, and cannot treat patients 
with laser or surgery if indicated. Also, 
annual exams for follow up of glaucoma 
is inadequate. The American Academy 
of  Ophthalmology  recommends  fol-
low up appropriate with the extent of 
disease,  and  certainly  more  frequent 
than annually.
Richard Nattis, MD
Long Island, N.Y.
Dear Dr. Nattis,
The  Aerospace  Medical  Certification 
Division’s general policy is that we prefer 
reports from a medical specialist who is 
knowledgeable in the treatment of such 
conditions and has experience with the clini-
cal treatment and potential complications 
(glaucoma, in this case). Dr. Lopez’ article 
mentions, more than once, that we require 
a report from a treating eye specialist, and 
does comment, in parentheses, optometrist 
or ophthalmologist (page 12). A summary of 
the potential multiple complexities of glau-
coma (insert, page 13), is also mentioned. 
The AMCD will not accept unsatisfactory 
reports regarding history of glaucoma, or 
pre-glaucoma deemed necessary for treat-
ment. Follow-up reports, for aeromedical 
purposes,  are  usually  required  annually, 
although the eye specialist may require more 
closely timed evaluations. The first-class 
pilot, then, will typically get a time-limited 
certificate for 12 months, even if the treat-
ing eye specialist is following more closely. 
The pilot jeopardizes timely certification 
if the eye report is vague, incomplete (for 
example, history is lacking), and as Dr. Nat-
tis implies, the AMCD judges the  medical 
report (glaucoma) to be inadequate—for 
example, if the doctor is not a medical spe-
cialist knowledgeable about the condition. 
Richard Carter, DO
AMCD Staff Physician
Blank certIfIcates to prInt?
Dear Editor,
Some concerns with the paperless 
record—which indeed is not paperless 
since we have to print out the certificate.
We have now introduced a number 
of  complex  systems  into  issuing  the 
medical certificate—now we must have 
functioning  computers  (we  will  not 
even begin to express the frustration 
with the PC and its evolution and op-
erating systems), Internet connections 
which where I practice go down with 
regularity, and of course printers and 
their limited life expectancy—with the 
“OLD” system if all else failed I could 
issue a certificate and could type it on 
a 1929 manual Smith Corona type-
writer—basic, primitive, but still very 
reliable—what if any of the above go 
down while examining an airman who 
needs his or her certificate to fly? Will we 
have available blank certificates to print 
in case of an above failure in any of the 
above chain of complex interfaces…? 
A.J. Bogosian, MD
Anacortes, Wash.
Hello, Dr. Bogosian,
There is something to be said for the 
reliable 1929 Smith Corona typewriter; I 
have a healthy respect for them, as many 
are still in use today. However, the enhance-
ments we are making to our technology 
infrastructure and our applications truly 
are for the benefit of AMEs and pilots. Our 
user community is more “computer savvy” 
than ever before; in fact, many believe we 
are “behind the power curve” when it comes 
to the use of technology.
In response to your question — yes, we 
will have a mechanism in place for you in 
the event of a failure that prevents you from 
accessing the AMCS. We are analyzing dif-
ferent solutions and will advise you of the 
solution prior to going “paperless.”
David Nelms
AMCD Program Analyst
HuntInGton’s DIsease
Dear Editor, 
Concerning  the  article  on  Hun-
tington’s disease in the recent Bulletin 
[“Huntington’s  Disease,”  Federal  Air 
Surgeon’s Medical Bulletin, vol. 50, no. 2, 
p. 16], it appears that the pilot described 
had no disease or symptoms of disease; 
he only reported the genetic marker for 
potential (probable) illness in the future. 
What was the basis for potentially dis-
qualifying this individual who presented 
no evidence of disease? Are we going to 
be requiring everyone who has a defined 
marker for future genetic disease to be 
extensively evaluated (as this individual 
was) prior to any evidence or symptoms 
of the disease?
George W. Jackson, MD
Associate Clinical Professor
Duke University
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Editor’s  Note:  This  is  a  very  interesting 
case. We would not have been aware that the 
individual had tested positive for the gene for 
Huntington’s disease if he had not voluntarily 
had himself tested. However, once we were 
informed, we had no choice but to ask for 
additional information to be sure that he was 
not symptomatic for the disease. We have not 
initiated a genetic screening program nor do 
we intend to do so.
In reply to: Huntington’s Disease: Case 
Report, by Robert Craig-Gray, MD
I would like to thank Dr. Craig-Gray 
for reporting this case  that demonstrates 
many of the concerns faced when evaluating 
potential sequelae of neurological diseases 
on aviator performance, as well as the com-
plexities that aviation medical examiners 
must deal with when confronted by rare 
diseases or diseases usually managed under 
the care of specialized providers. Hunting-
ton’s disease poses some particularly difficult 
challenges, as most individuals remain nor-
mal through much of their early life, with 
a wide range in the age of onset, and once 
the disease becomes manifest, progressive 
neurological and psychiatric problems ensue 
unrelentingly.
A medical status report was obtained 
from this airman’s neurologist and revealed 
no detectable neurological disease or dis-
ability. It is encouraging that this aviator 
also presented with no abnormalities on 
neuropsychological testing; however, it is 
important to know that even in early disease, 
subtle but potentially important cognitive 
deficits  may  develop  before  diagnostic 
threshold is reached [1].
I do wish to correct the statement: “Al-
though only 50% of those testing positive 
for the disease actually develop symptoms, 
currently  there  is  no  further  predictive 
capacity to determine who will become ill 
and who will remain disease-free.” In fact, 
the disease has nearly 100% penetrance for 
those testing positive (>42 CAG repeats). As 
you mentioned, disease severity, and earlier 
onset is associated with greater number of 
CAG  [cysteine-adenosine-guanine]  repeats, 
and you may have intended to refer to the 
findings that 50% of the variability in disease 
severity and age of onset are explained by 
CAG repeat length [2].
The number of CAG repeats in humans 
is highly variable, but the normal range is 
11-34 CAG copies, and more than 42 repeats 
indicates  a  confirmed  genetic  diagnosis 
of Huntington’s gene in most labs. That 
being said, individuals with an “intermedi-
ate” number of CAG repeats (34-42 CAG 
repeats),  still  demonstrate  a  behavioral 
phenotype, with depressive features relative 
to normal healthy controls [3], and at the 
upper end of this range, the full Hunting-
ton’s phenotype is incompletely penetrant. 
It would be of interest to know how many 
CAG repeats this airman had.
You mention that the airman should also 
report any changes in his medical condition 
immediately to the FAA and cease aviation 
operations per Title 14 CFR §61.53, which 
restricts operation of an aircraft with any 
medical [known] deficiency. One difficulty 
Huntington's  from page 2 with this approach is that individuals with 
neurodegenerative  disease  are  often  un-
aware of developing cognitive difficulties 
(anosognosia), and regular screening such 
as annual administration of Cogscreen-AE 
or  equivalent  neuropsychometric  testing 
would help detect cognitive decline that 
would impair safe operation of an aircraft, 
potentially before the aviator or their peers 
may readily recognize a deficit.
Richard Ronan Murphy, MBChB
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Three OAM Staff Honored by the Aerospace Medical Association
I
n an unusual and welcome surprise, 
two Office of Aerospace Medicine 
staff members were elected Fellows 
of the Aerospace Medical Association 
(AsMA) and one received a prestigious 
national award during Honors Night 
celebrations at the AsMA 83rd Annual 
Scientific  Meeting  held  last  May  in 
Atlanta, Ga.
Eastern  Region  Flight  Surgeon 
Harriett Lester and her sister, Benisse 
Lester, the Chief Medical Officer for the 
Federal Motor Carrier Safety Admin-
istration (FMCSA) and a FAA senior 
aviation  medical  examiner  (AME), 
were both made Fellows of AsMA on 
the same night. The story gets even 
better. Aerospace Medical Education 
Division Manager Brian Pinkston and 
his wife, Cheryl Lowry—a U.S. Air 
Force Flight Surgeon—were also among 
the 24 AsMA Fellows elected for 2012.
“It was quite a surprise,” said Federal 
Air Surgeon Dr. Fred Tilton. “I’ve never 
seen relatives elected before, and I’ve 
never seen a husband and wife elected 
before. And here we have Brian and his 
wife, and Harriet and her sister—who is 
basically my counterpart at FMCSA—
all elected at once!”
Although not related or married to 
anyone  else  who  received  an  AsMA 
award  this  year,  CAMI’s  Research 
Physiologist David “Andy” Self received 
the AsMA Arnold Tuttle Award for 
original  research,  which  investigated 
the physiological responses to altitude 
hypoxia. This information is used to 
address improvements in countermea-
sures and oxygen equipment design for 
commercial and general aviation. The 
research was published as an Office 
of Aerospace Medicine Report and in 
the Aviation, Space, and Environmental 
Medicine Journal.
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OAM Physicians On Call 
Part 1
Standing By To Help
By Richard Carter, DO, MPH
a 
vIatIon  meDIcal  examiners,  we 
challenge you to limit unnecessary 
deferrals, which helps us to minimize 
the backlog of deferred exams. Key to 
this initiative is an appeal to you to issue 
certificates when you can. 
The  following  two  lists  from  the 
Office of Aerospace Medicine (OAM) 
should help you reduce the number of 
unnecessary  phone  calls  to  Aerospace 
Medical Certification Division (AMCD) 
in Oklahoma City for verbal authoriza-
tions. If you have an unusual case and 
need guidance, though, please call. 
The  medical  officers  (AMCD, 
Regional Flight Surgeons, and Inter-
national/Military Regional Office) are 
available to you for such case discus-
sions. A team effort is needed to make 
this process successful.
In Part 1 of this article, we address 
examples that do not require you to call 
us (see list this page). Print the list, and 
paste it in a handy spot for reference.
Calling AMCD/RFS is easy. Call 
our designated number (include Web 
link to AMCD and Regional Flight 
Surgeon  phone  numbers).  You  can 
call the AMCD or a Regional Flight 
Surgeon for verbal authorization. 
Whom to call. We advise, in general, 
that third-class airman inquires should 
go to your Regional Flight Surgeon. 
The AMCD more commonly answers 
calls about first- and second-class pi-
lots, and specifically detailed medical 
inquires (for example, central serous 
retinopathy, renal cancer). Many AMEs 
already do this. The AMCD number 
405-954-4821/option 6, links you to 
dedicated operators that will route you 
to the physician on call. Please follow 
operator instructions; you will be asked 
your AME number, PI or application 
ID number. If we are not immediately 
available, we will try to call back the 
same day. We may also ask for an after-
hours call back number (usually your 
cell number), as we may call back after 
normal work hours. 
Issue when you can. A phone call to 
the AMCD is not always required. The 
protocol section of the AME Guide lists 
conditions allowable for AME to initial 
issue (example, hypertension, diet/exer-
cise control of diabetes). Complications 
can occur, and we invite you to call 
about abnormal labs, ECGs, etc. AMEs 
that do initial issue will need to send in 
medical reports. DO NOT mail, fax, 
conDItIons tHat allow tHe ame to Issue
•	Motion sickness – resolved.
•	Myringotomy – resolved.
•	Eardrum perforation – resolved.
•	Esophoria/exophoria – no adverse complications, no diplopia. 
•	LASIK – less than two years – we need 8500-7. If favorable, issue.
•	LASIK – more than two years – comment no adverse complications (AME 
comments block 60), issue.
•	Acute nephritis, 3 months status post, resolved, issue with favorable reports.
•	Kidney stone history, no retained kidney stone.
•	Melanoma, < .75 mm, favorable report, issue.
•	Hypertension (see Hypertension Protocol).
•	Diet/exercise diabetes (see Diet/Exercise Diabetes Protocol).
•	Multifocal  intraocular  lens  (see  Protocol  for  Binocular  Multifocal  and 
Accommodating Devices).
•	Musculoskeletal injury (see Musculoskeletal Protocol).
•	Benign prostatic hypertrophy/medication, examples (note: AMCD does re-
quire comment in block 60 that the following medications are well tolerated):
  ♦ Detrol (tolterodine): acceptable 
  ♦ Enablex (darifenacin): acceptable 
  ♦ Vesicare(solifenacin): acceptable
  ♦ Avodart (dutasteride): acceptable
  ♦ Santura (trospium): acceptable
  ♦ Uroxatral alfuzosin): acceptable
  ♦ Flomax (tamsulosin): acceptable
  ♦ Rapaflo (silodosin): acceptable
•	Ditropan (oxybutynin); antispasmodic/anticholinergic: is NOT acceptable 
for aeromedical purposes.
•	Gout/medication, examples (note AMCD does require comment in block 
60 that medications are well tolerated):
  ♦ Colcrys (colchicine): allowable.
  ♦ Uloric (febuxostat): allowable.
  ♦ Zyloprim (allopurinol): allowable.
  ♦ Benemid (probenecid): allowable.
•	Erectile dysfunction meds, example (note AMCD does require comment in 
block 60 that medications are well tolerated):
  ♦ Viagra (sildenafil citrate): 6 hrs. no fly.
  ♦ Levitra (vardenafil): 36 hrs. no fly.
  ♦ Cialis (tadalafil): 36 hrs. no fly.
•	Asthma, and medication, is rarely used.
•	Peptic ulcer (see Peptic Ulcer Protocol).
•	Cholelithisis, asymptomatic: issue.
•	Traumatic  pneumothorax,  3  months  status  post,  resolved:  issue  with 
favorable reports.
or otherwise send in duplicates of the 
same reports. Simply put, AMEs can 
issue cases that allow for an Eligibility 
Letter (see below list – note, this is not a 
complete list of conditions that qualify 
for an Eligibility Letter but a sample 
of typical questions/conditions AMEs 
frequently call about. See also the list 
of ECG Issues on page 6.). 
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Example:  The  airman  provides  a 
summary report from the urologist, his-
tory of kidney stones, now resolved. The 
most recent imaging (kidneys, ureter, 
and   bladder) demonstrates no retained 
kidney stone. The AME does issue, trans-
mits the new exam, and faxes reports to 
the AMCD (fax 405-954-4300), with 
a coversheet. Do you need to call? The 
answer is no. Again, do not mail, fax, or 
otherwise send in duplicate reports, as this 
creates delays in certification. 
Team effort. We need your help to 
limit unnecessary deferrals. Many com-
plex medical conditions do eventually get 
a waiver (Special Issuance or Statement 
of Demonstrated Ability), and we will 
help you with the certification process. 
Many thanks to the Regional Flight 
Surgeons that have assisted us with the 
on-call program. Have you experienced 
calling the AMCD in Oklahoma and 
been  surprised  to  be  talking  to  Dr. 
Goodman in California or Dr. Lester 
in New York? Regional Flight Surgeons 
have assisted us by taking calls for us, 
so we can balance our on-call workload 
with demands of our backlog of deferred 
cases  waiting  for  review.  Thanks  to 
Drs. Ray, Goodman, Salazar, Lester, 
Northrup, and Jones for participating 
in this special certification project. The 
Aerospace Medical Certification Divi-
sion medical staff, Drs. Courtney Scott, 
Brian Johnson, Bill Mills, Ben Zwart, 
and Steve Schwendeman all participate 
in the on-call process. 
Good  news.  Dr.  Judy  Frazier  is 
now fully trained and ready for calls, 
so you will be talking to her soon! The 
International  AMEs  communicate 
with the International Regional Flight 
Surgeon Office, Dr. Brian Pinkston, 
and  International  Program  Analyst 
Leah  Olson.  We  coordinate  efforts 
with the International office to address 
International AME inquires. Together, 
this team effort expedites the medical 
certification of pilots. 
In Part 2 of this series, we will discuss 
details of the verbal authorization needed 
for Special Issuance.
Q
Dr. Carter is a medical review officer in 
the Aerospace Medical Certification Division.
Post-Traumatic Stress Disorder 
Case Report, by Nathaniel B. Almond, MD, MPH 
Airmen may present for 
evaluation with a history of post- 
traumatic stress disorder (PTSD) 
or with ongoing symptoms of 
PTSD. A thorough history is 
important for confirming that 
symptoms have resolved and 
that the airman is not taking 
medication for PTSD. This article 
presents a case report of a first-
class pilot applicant with ongoing 
symptoms of PTSD and includes a 
brief review of PTSD. 
Background
a   
32-year-olD male with 100 flight 
hours applied for first-class medi-
cal certification with ongoing PTSD 
due to a stressful event 8 years ago 
while in the military. During convoy 
operations in enemy territory, he drove 
a vehicle over an improvised explosive 
device (IED), causing it to detonate and 
the vehicle to catch fire. While escaping 
from the vehicle, he was shot multiple 
times in the arm and leg, but he did not 
sustain any head injury. He now admits 
to generalized anxiety, fear of meeting 
new people, and weekly nightmares and 
Post-traumatiC stress DisorDer etiology 
PTSD is an anxiety disorder that occurs after the experience or witnessing of 
a traumatic event. The person’s response to the event must involve intense 
fear, helplessness, or horror. Symptoms vary but can be classified into three 
categories: 1) reexperiencing of the traumatic event, 2) avoidance of situations 
associated with the trauma and numbing of general responsiveness to keep 
from thinking about the event, and 3) symptoms of increased arousal . Symp-
toms from all three categories must be present for more than 1 month, and the 
disturbance must cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning. The many symptoms 
that people with PTSD may experience include anxiety, hyper-vigilance, hyper-
arousal, avoidance, reexperiencing the event (e.g., nightmares, flashbacks, or 
intrusive thoughts), anhedonia, reduced ability to feel emotions, being easily 
startled, difficulty concentrating or completing tasks, bursts of anger, insomnia, 
and irritability (1,2).
PTSD is a common diagnosis: 6.8% of Americans will experience PTSD in 
their lifetime. It is particularly prevalent in those who have served in combat, 
including aviation personnel. (3) Thirty percent of Vietnam veterans have PTSD, 
while PTSD prevalence estimates in veterans from Iraq and Afghanistan has 
ranged from 6 to 20% . Depression and alcohol use are also common with 
PTSD. The onset of symptoms in relation to the event, as well as the duration 
of symptoms, greatly varies (1,2).
Treatment of PTSD includes cognitive behavioral therapy and anti-depressant 
medication (selective serotonin reuptake inhibitors). Policies and programs exist 
across many organizations to assist individuals exposed to stressful events in an 
effort to minimize PTSD symptoms. These programs range from Traumatic Stress 
Response within the Department of Defense to the Critical Incident Response 
Program by the Airline Pilots Association. For example, the Critical Incident 
Response Program works to mitigate PTSD through pre-incident education 
and post-incident accident crisis intervention through crewmembers who have 
received counseling training. Both primary prevention rapid response to victims 
is important in both the civilian and military settings of traumatic events (2,3,4).
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1.  If an airman has a heart rate less 
than 50, have the airman exercise 
in place and repeat the ECG. If 
the heart rate goes up above 50, 
send us both ECGs (in case this 
happens  again  down  the  road), 
and you can clear the airman.
2.  This  also  goes  for  a  significant 
first-degree AV block. Exercise the 
airman in place, and if the block 
becomes less, you may clear the 
airman.
3.  If an airman has a heart rate over 
110–sinus tachycardia, perhaps—
have the airman relax a bit and 
repeat the graph. If the rate drops 
below 110, send us the graph and 
clear the airman.
4.  Two  or  more  premature  atrial 
contractions  or  ventricular  con-
tractions  on  an  ECG  requires 
the applicant to have a maximal 
nuclear stress test. If this has been 
previously worked up, you do not 
need to provide a new evaluation.
5.  If the airman demonstrates new 
onset  of  complete  RBBB  (right 
bundle  branch  block);  in  other 
words, this has not been seen on 
previous graphs, then you are to 
have the airman undergo a maximal 
nuclear stress test. Note: All stress 
testing in first- and second-class 
airmen should be maximal nuclear 
stress  testing  (unless  we  specify 
otherwise in our letter to you).
6.  An airman who has an incom-
plete RBBB pattern on previous 
electrocardiograms,  and  then 
demonstrates a complete RBBB, 
does not require an evaluation.
7.  An airman with a new onset of 
a  complete  left  bundle  branch 
block is to provide a cardiovascular 
evaluation and a pharmacologic 
nuclear stress test. This is one of 
the conditions where we will accept 
a pharmacologic stress test. Airmen 
with a LBBB demonstrate what ap-
pears to be an area of ischemia in 
the septum, and the pharmacologic 
stress test helps better determine if 
there is actual ischemia.
8.  An airman with left anterior or 
posterior hemiblock must demon-
strate an absence of coronary artery 
disease, so a maximal nuclear stress 
test is required.
9.  Limb lead III is the most variable 
lead. This lead sometimes is af-
fected by respiration, which can 
falsely indicate that the airman had 
a previous inferior infarction. So 
if you have a small R-wave with a 
deep S-wave in that lead, and even 
perhaps in lead aVF, you need to 
perform  an  ECG  in  inspiration 
and  again  in  expiration.  If  the 
S-wave disappears and you get a 
larger R-wave, you can clear the 
airman—but don’t forget to pro-
vide us all these graphs.
10.  An airman who has ST- and T-wave 
changes that suggest ischemia or 
left  ventricular  hypertrophy  re-
quires an evaluation if one has not 
been previously performed for this 
reason. These situations require a 
cardiovascular evaluation, perhaps 
an echocardiogram, and definitely 
a maximal nuclear stress test. 
ECG Normal Variant List 
These are considered normal ECG vari-
ants and not reasons to defer the applicant
•	Sinus  bradycardia.  Age  50  and 
younger — if the heart rate is 45 or 
greater; age 50 and older — if the 
heart rate is 49 or greater
•	Wandering atrial pacemaker
•	Low atrial rhythm
•	Ectopic atrial rhythm
•	Indeterminate axis
•	First-degree AV (atrioventricular) 
block with PR interval less than 
0.21 in age 50 and younger
•	Mobitz Type I Second Degree AV 
(atrioventricular) block (Wencke-
bach phenomenon)
•	One  premature  ventricular  con-
traction or atrial contraction on a 
12-lead ECG
•	Incomplete RBBB 
•	Intraventricular conduction delay
•	Early repolarization
•	Left  ventricular  hypertrophy  by 
voltage criteria only
•	Low voltage in limb leads (may be a 
sign of obesity or hypothyroidism)
•	Left  axis  deviation,  less  than  or 
equal to -30 degrees
•	rSR’ in leads VI or V2, ORS interval 
less than 0.12 msec R>S wave in 
VI without other evidence of right 
ventricular hypertrophy
•	Sinus arrhythmia
•	Sinus tachycardia: Any age — if the 
heart rate is less than 110
•	Left atrial abnormality
•	Short QT
Note: If a first-class airman does 
not have a current resting ECG on 
file but we have any type of stress 
test  (pharmaceutical  stress,  Bruce 
stress, nuclear stress, or stress echo-
cardiogram) that was accomplished 
within the last year, we can accept 
without  writing  out  for  a  current 
resting ECG; however, we do need 
the tracings from any of these tests. 
A cardiac cath and a Holter monitor 
test are not acceptable in place of a 
resting ECG.
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flashbacks. He also admits to drinking 
heavily on and off in the years since 
the event. Currently, he does not drink 
alcohol. He is divorced. He currently 
has a 30% disability rating for PTSD 
from the Veteran’s Administration. His 
psychiatric exam is notable for anxious 
affect but is otherwise normal.
Aeromedical Concerns
The primary aeromedical concern for 
this case is that the airman’s ongoing 
symptoms of PTSD could compromise 
his ability to safely operate an aircraft. 
Specifically,  his  symptoms  such  as 
flashbacks and anxiety could decrease 
his ability to focus and concentrate on 
safely  piloting  and  could  be  acutely 
incapacitating in the cockpit. Substance 
abuse associated with PTSD and fatigue 
resulting  from  nightmares  may  also 
compromise safe flying. 
In addition to this airman’s symp-
toms, other symptoms of PTSD could 
also affect flight safety. These include 
1) numbing of general responsiveness, 
which could slow reaction times, 2) 
avoidance, which could affect behavior 
to make correct decisions, and 3)an 
autonomic hyper-arousal state, which 
could  also  degrade  concentration, 
situational awareness, and the ability 
to manipulate controls. Anxiety might 
also originate as a fear of flying (5,6).
Under Title 14 of the Code of Federal 
Regulations (CFR) parts 67.107, 67.207, 
and  67.307,  (c)  No  other  personal-
ity disorder, neurosis, or other mental 
condition that the Federal Air Surgeon, 
based on the case history and appropri-
ate, qualified medical judgment relating 
to the condition involved, finds:
1. Makes the person unable to safely 
perform the duties or exercise the 
privileges of the airman certificate 
applied for or held; or 
2. May reasonably be expected, for 
the  maximum  duration  of  the 
airman medical certificate applied 
for or held, to make the person 
unable to perform those duties or 
exercise those privileges.
In  this  context,  PTSD  would  be 
considered a “neurosis or other mental 
condition” (in part c). Any airman with 
a history of ongoing PTSD symptoms 
or a history of PTSD should be deferred 
to the FAA for further consultation.
Outcome
The  aerospace  medicine  residents 
discussed the case and decided more 
information  was  required  regarding 
this applicant: specifically, additional 
evaluation of alcohol use and neuro-
psychological testing, as well as original 
documentation  of  the  diagnosis  of 
PTSD. The FAA denied  the certificate 
until these documents are provided for 
further evaluation. If the applicant does 
indeed have ongoing PTSD symptoms, 
he would not receive a certificate.
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Biennial Survey of Pilot Satisfaction Initiated
By Katrina Avers, PhD
t
He offIce of Aerospace Medicine 
is mailing invitations this month 
to a randomly selected sample of pilots 
to complete a survey regarding their 
experiences and satisfaction with the 
airman medical certification process. 
The survey is a biennial survey we 
administer to be in compliance with   
Executive Order No. 12862, “Setting 
Customer Service Standards,” and the 
Government Performance and Results 
Act of 1993. The information obtained 
is used to evaluate the degree of customer 
satisfaction  with  Aerospace  Medical 
Certification  Services,  identify  areas 
in  which  the  FAA  may  improve  its 
services to airmen, and assess change in 
customer satisfaction as a result of those 
improvements. Invitees are in a unique 
position to provide the FAA valuable 
feedback that will affect all pilots. We 
hope to get a large response so that we 
can get meaningful data to share with 
you in a future issue.
Dr. Avers is a research psychologist in the 
Civil Aerospace Medical Institute’s Aerospace 
Human Factors Research Division.
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Transverse Myelitis
Case Report 
by Jonathan F. Stinson, MD, MPH
Transverse myelitis is a rare 
but potentially debilitating 
neurological condition caused by 
spontaneous, usually idiopathic 
inflammation of both grey and 
white matter of the spinal cord. 
This case report evaluates an 
airline pilot with this disorder 
and the requirements necessary to 
return the airman to flying. 
History
t
HIs  case  Involves a 53-year-old 
airline  pilot  with  approximately 
16,000 hours, who was in his usual state 
of good health prior to this incident. 
He was admitted to the hospital with 
symptoms of progressive loss of light 
touch, vibratory, and position sense, 
starting in his feet and working its way 
up to the level of the chest, including 
upper extremities from hands to mid 
forearm. He had no signs of muscle 
weakness or reflex abnormalities. 
A cervical MRI revealed a 6-mm 
  lesion of the posterior part of the cervical 
spinal cord at the C5-6 level with some 
surrounding edema and swelling of the 
cord at that level. MRI of brain and tho-
racic cord was normal. Cerebrospinal 
fluid showed no evidence of inflamma-
tion, with no white cells and a normal 
protein of 54 mg/dl. Immunological 
studies were normal, as was an IgG 
index and 24-hour IgG synthesis rate. 
There were no oligoclonal bands seen, 
and CFS and Lyme disease antibodies 
were negative. Serum B-12, folic acid, 
and ESR were all normal. 
The  airman  was  admitted  to  the 
hospital and treated for five days with 
high-dose IV methylprednisolone, 1gm 
daily, followed by a six-day taper. At 
the time of discharge, all symptoms 
resolved, with the exception of residual 
numbness of the fourth and fifth digits 
of both hands. 
etiology of transverse myelitis
Transverse myelitis is a relatively rare neurological disorder caused by inflam-
mation of the spinal cord, creating a demyelinating lesion, typically involving 
both sides of the cord, hence its transverse or bilateral nature. These lesions 
are usually at one level only but can occasionally exist at multiple levels. The 
resulting inflammation damages or destroys myelin, compromising conduction 
between the brain and muscles or sensory organs distal to the lesion. Symp-
toms of transverse myelitis can evolve over several hours to as long as several 
weeks. It often begins as a sudden onset of lower back pain, muscle weakness, 
or abnormal sensations in the toes and feet. However, it can rapidly progress 
to more severe symptoms, including paralysis, urinary retention, and loss of 
bowel control. Diagnosis is made by clinical history, physical findings, and a 
spinal cord lesion seen on MRI. Some patients may recover from transverse 
myelitis with minor or no residual problems, while others suffer permanent 
impairments that affect their ability to work or even carry out activities of 
daily living. The majority of cases involve single episodes, but some can have 
a recurrence of symptoms.(1) 
It is estimated that about 1,400 new cases of transverse myelitis are diagnosed 
each year in the United States, and approximately 33,000 Americans have some 
type of disability resulting from the disorder. It can occur in all age groups, 
but peaks occur in the 10-19 and the 30-39 age ranges. There appear to be no 
inherited, ethnic, or gender differences in incidence. One study estimated the 
incidence to be about 4.6 cases per million per year.(2)
Transverse myelitis can have many different etiologies. It is thought that about 
45% are parainfectious or related to infections. Infectious agents suspected of 
causing transverse myelitis include varicella zoster, herpes simplex, cytomegalo-
virus, Epstein-Barr virus, influenza, echovirus, human immunodeficiency virus, 
hepatitis A, and rubella. Bacterial skin infections, otitis media, Lyme disease(5) 
and Mycoplasma pneumoniae have also been associated with the condition. 
In the United States, up to 21% of cases can be a presenting sign of multiple 
sclerosis.(4) It is also recognized as a complication of some autoimmune dis-
eases such as systemic lupus erythematosus, Sjögren’s, or sarcoidosis, (7) post-
infectious myelopathy, spinal cord infarct, and neuromyelitis optica.(2) Some 
cases can be the result of spinal cord infarct or be a presenting sign of multiple 
sclerosis. In about 21% of cases, the etiology remains unknown, even after a 
long-term follow-up.(3)
Treatment is dependant on determining a specific etiology and may be directed 
at an underlying infectious etiology, if discovered. Generalized treatments such 
as corticosteroids are of use in cases secondary to the autoimmune disorders, 
but there is some debate over their effectiveness in idiopathic acute transverse 
myelitis. 
Neurology follow up at six months 
revealed  a  stable  neurological  exam, 
with only the residual sensory deficits 
noted  before.  His  MRI  showed  im-
provement, with decreasing gadolinium 
enhancement of the C5-6 lesion and no 
evidence of new lesions. After reviewing 
his case, his aviation medical examiner 
deferred for special issuance, which was 
granted for 12 months contingent upon 
submission of MRI cervical spine results 
and a satisfactory current status report. 
Aeromedical Concerns
These  can  be  divided  into  three 
categories:  acute  disease  concerns, 
prognostic concerns about the risk of 
recurrence, and concerns about residual 
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Acute Concerns. Acutely, the condi-
tion is obviously disqualifying under 
Title 14 of the Code of Federal Regula-
tions parts 67.109, 67.209, and 67.319, 
where it states neurologic standards are: 
(a) No established medical history 
or  clinical  diagnosis  of  any  of...  (3) 
A transient loss of control of nervous 
system function(s) without satisfactory 
medical explanation of the cause.
(b) No other seizure disorder, distur-
bance of consciousness, or neurologic 
condition that the Federal Air Surgeon, 
based on the case history and appropri-
ate, qualified medical judgment relat-
ing to the condition involved, finds…
(1) Makes the person unable to safely 
perform the duties or exercise the privi-
leges of the airman certificate applied 
for or held; or (2) May reasonably be 
expected, for the maximum duration of 
the airman medical certificate applied 
for or held, to make the person unable 
to perform those duties or exercise those 
privileges. Essentially, airmen need to 
have full control of sensory and motor 
function to safely operate an aircraft. 
Prognostic  Concerns.  Once  the 
condition has resolved or stabilized, the 
concern is directed to the likelihood of 
recurrence and what, if any, residual 
disability is present. Up to 21% of idio-
pathic acute transverse myelitis cases in 
the U.S. may be the presenting sign of 
multiple sclerosis, which implies a high 
likelihood that neurological symptoms 
will  recur.  If  multiple  sclerosis  has 
been ruled out, the risk of recurrence 
is very low. 
Residual  Disability  Concerns. 
Recovery from transverse myelitis usu-
ally begins between two and 12 weeks 
following onset of symptoms and may 
continue for up to two years in some 
patients, many of whom are left with 
considerable disabilities. Approximately 
one-third will recover, with minimal 
to no disability; about one-third with 
have significant residual recovery, and 
the remainder will never show signs of 
recovery. Following stabilization, the 
airman must be assessed by a neurologist 
for residual deficits and, if significant, 
medical flight testing may need to be 
considered.  A  Statement  of  Demon-
strated Ability may need to be issued. 
Outcome
This airman was fortunate to have a 
reversible case of idiopathic acute trans-
verse myelitis. He was effectively treated 
with corticosteroids, and his symptoms 
rapidly disappeared. Six months after 
the  incident,  he  had  only  minimal 
intermittent  numbness  of  his  fourth 
and fifth digits, no loss of strength, or 
any other neurological symptoms. He 
was found ineligible for medical cer-
tification under 14 CFR parts 67.113, 
67.213, and 67.313 but was granted an 
authorization for special issuance for 
one year. This was contingent upon 
meeting the maintenance requirements 
of his current medical certification and 
providing a current status report from 
his neurologist, including interim his-
tory, prognosis, follow-up plan, medica-
tions (including type, dosage, and side 
effects), current MRI of the cervical 
spine, and the results of any other studies 
that are deemed appropriate. 
Q
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Back To Basics: 
Cardiovascular Disease 
and Stenting 
Case Report, by  
Valerie Johnson, MD, MPH
Introduction
Coronary artery disease (CAD) is a 
significant cause of death and perma-
nent disability in America. This con-
dition may have an insidious onset 
but will most certainly always prog-
ress to become symptomatic or precipi-
tate a cardiac event. Treatment entails 
medical therapy alone or a combina-
tion of revascularization procedures 
and medications. This report will re-
view the case of an airman with CAD 
who underwent a percutaneous trans-
luminal coronary angioplasty with 
stent placement; and the subsequent 
ramifications on flight safety of this 
condition. 
Background
a 
46-year-olD  commercIal  pilot 
presents to his aviation medical 
examiner (AME) for his annual second-
class medical exam. He has flown over 
8,000 hours and has been healthy until 
a year ago, when he felt burning and 
pressure in his chest while working in 
his backyard. His symptoms continued 
intermittently over the weekend and 
did not seem to improve with rest. He 
has been an avid runner most of his 
adult life and his medical history is 
significant only for hyperlipidemia for 
12 years. He was seen by his primary 
physician and was initially treated for 
gastroesophageal reflux. However, his 
chest  pressure  and  burning  did  not 
completely abate over the next 6 weeks; 
hence, he was finally referred to a cardi-
ologist. His family history is significant 
for hypertension, hyperlipidemia, and 
diabetes in his parents who are both 
still alive at age 74. 
During his cardiology evaluation, 
his  left  anterior  descending  artery 
(LAD) was 100% occluded, with his 
distal myocardium supplied solely by 
collateral circulation. Additionally, his 
right coronary artery (RCA) had a 40% 
lesion. Therefore, an angioplasty was 
performed, and a drug-eluting stent was 
inserted into his LAD. This procedure 
was performed about 11 months ago. 
He had an unremarkable recovery and 
is back to walking/running 2-3 miles a 
day, 5-6 days a week. His medications 
include ramipril (Altace), clopidogrel 
(Plavix), Aspirin, atorvastatin (Lipitor), 
and esomeprazole (Nexium).
The month prior to his presentation 
to his AME’s office, the airman com-
pleted a maximal-graded test without 
exercise-induced symptoms and normal 
exercise ECG response. He achieved 
100% of his predicted maximum heart 
rate, and his left ventricular ejection 
fraction (LVEF) was 62%. His status 
report from the cardiologist and labs 
were favorable. A requirement for all 
first-  and  second-class  airmen  is  to 
provide the FAA with a six-month post-
event treatment coronary angiogram. 
In the current case, the airman had 
a catheterization that demonstrated a 
patent LAD stent and no progression 
of the RCA disease. The airman asked 
his AME if this medical history and 
evaluation were acceptable to the FAA 
and whether he would be allowed to 
continue with his primary occupation. 
Aeromedical Concerns and  
Role of the AME 
The aeromedical concern related to 
coronary artery disease is the possibility 
of a severely incapacitating event that 
would gravely impact the performance 
of flying duties.3 This may manifest 
as sudden cardiac death, myocardial 
infarction, angina, or ventricular dys-
rhythmias.  The  occurrence  of  such 
catastrophic events, both in a single-
piloted plane or commercial aircraft, 
could result in dire consequences on 
the airman’s health and on public safety.
Coronary artery disease is disqualify-
ing for first-, second-, and third-class 
medical certificates per Title 14 Code 
of Federal Regulations (CFR) 67.111, 14 
CFR 67.211, and 14 CFR 67.311, respec-
tively. Stents are dealt with in a similar 
fashion as myocardial infarctions, coro-
nary angioplasty, and coronary artery 
bypass graft. A six-month post-event 
recovery  period  is  necessary  before 
consideration can be made by Medical 
Appeals. The airman needs to provide 
the hospital admission and discharge 
summaries,  cardiac  catheterization 
report, and any operative reports from 
whatever corrective surgical procedure 
is performed. 
Required  information  includes  a 
current status report from the treating 
physician. This should address a current 
performance assessment of the airman, 
as well as an estimate of his exercise 
program and capacity. It should com-
ment on the modifiable risk factors for 
coronary heart disease such as smoking 
history, diet, physical inactivity, obesity, 
presence of hypertension, diabetes, and 
hyperlipidemia. Weight, height, (BMI), 
and  blood  pressure  measurements 
should also be indicated. 
A current list of medications with 
any explanation for changes in doses 
or  drugs  should  also  be  forwarded. 
Any  laboratory  data  related  to  this 
condition is required for submission; 
this list will include the following at a 
minimum: fasting blood sugar, total 
cholesterol,  LDL/HDL  cholesterol, 
and triglycerides. For third-class medi-
cal certification, a maximal stress test 
(Bruce protocol) must be performed. 
Ideally, this test should be completed 
to  100%  of  the  airman’s  predicted 
maximal heart rate. 
For first- and second-class airmen, a 
maximal nuclear stress test is required. 
Extenuating circumstance precluding 
adherence to these guidelines may be 
considered on a case-by-case basis. Note 
that the Aerospace Medical Certifica-
tion Division will require the airman 
to submit all of the ECG tracings for 
inclusion in their AMCD medical case 
file (W. Silberman, personal commu-
nication March 18, 2010).
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Outcome
After the airman and his AME com-
pleted all the requirements listed above, 
his case was processed. He subsequently 
received a Special Issuance authoriza-
tion, valid for 12 months. 
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etioLoGy of cArdioVAscuLAr diseAses
Cardiovascular diseases (CVDs) continue to be a leading cause of death in the 
United States, according to the American Heart Association.1 In fact, CVDs 
have accounted for more deaths annually than any other major cause of death 
since 1900, except for 1918. In 2006, the U.S. prevalence of coronary artery 
disease was 7.9% (17.6 million Americans), and CAD deaths were estimated 
at over 425,000. Airmen are required to possess a strict standard of health in 
order to fly; hence, they may be considered to be healthier than the general 
population. However, it would be naïve to assume that they are immune to this 
insidious disease. Consequently, the significance of CAD in public health and 
aviation safety cannot be overlooked. Military and commercial aviation have 
long recognized the role of sudden cardiac death as a (preventable) cause of loss 
of life and aircraft.2 Coronary artery disease is usually progressive; new lesions 
continually develop, and established lesions become narrower. Its true, natural 
history is not completely known because most diagnosed patients are treated 
with medications or revascularization. Moreover, the data to predict the natural 
history of aviators with CAD are lacking. However, compared with the general 
population, airmen are typically healthier, are less symptomatic, and have fewer 
risk factors. Aeromedical dispositions for CAD are based on clinical popula-
tion data and may not be completely applicable to aviators. There are studies 
that show that the severity of the anatomic CAD strongly predicts survival and 
other clinical events.2 This fact allows for regulatory bodies to consider aviators 
with varying degrees of CAD to maintain their licenses, albeit often restricted. 
The risk of recurrence of a cardiac event that would compromise the safety 
of the airman and the safety of the public should be considered each time a 
medical certification is requested by the affected flyer. Epidemiologic studies 
and long-term follow-up of healthy civilian personnel, as well as patients with 
normal coronary arteries, as evidenced by angiography, have been performed 
and have established 10-year annual coronary event rates of up to 0.65%.3 A 
review of healthy USAF aviators revealed a five-year yearly coronary event rate 
of 0.15% in the oldest age group (45-54 year-olds).4 These “normal” rates may 
then be compared to those airmen with CAD in an attempt to estimate their 
risk. Moreover, a five-year study of second-generation stents identified factors 
such as the presence of diabetes and multivessel disease as predictors of both 
restenosis and non-restenosis events. Five-year mortality was predicted by older 
age, reduced LVEF, and length of index lesion.5 Some of these variables can be 
followed as potential markers of disease progression.
Several modalities can be used to manage patients with CAD. This report will 
only comment on revascularization. Coronary artery revascularization procedures 
include percutaneous coronary intervention (PCI, catheter-based techniques 
such as angioplasty and stent insertion) and coronary artery bypass graft surgery 
(CABG). These methods are considered palliative due to the progressive nature 
of CAD. In cases of successful revascularization after short-term follow-up (6-
12 months), future cardiac events will likely result from progression of CAD 
in another vessel. Novel, clinically significant lesions (>50% occlusion) may 
develop at other sites at annual rates of 7-15% within two years of interventional 
procedure.6 In a USAF database, 122 former military aviators who underwent 
revascularization without prior cardiac events were followed for occurrence of 
an additional event. Approximately half underwent a PCI (mostly angioplasty), 
and the other half received a CABG. No cardiac deaths were observed within 
five years, and only two developed a myocardial infarction (both past two-year 
follow-up). After the exclusion of repeat revascularizations within six months 
of the index event, the average annual event rates were 1.0%, 2.7%, and 3.6% 
per year, at one, two, and five years, respectively.7 12   The Federal  Air Surgeon's Medical Bulletin  • Vol. 50, No. 3  •       
Wallenberg’s Syndrome
Case Report, by  
John J. Venezia, DO, MPH
Abstract 
Wallenberg’s syndrome is a 
neurological condition caused by a 
brain stem stroke. It is also known 
as lateral medullary infarction 
or posterior inferior cerebellar 
artery infarction. The constellation 
of presenting symptoms helps 
to identify the location of the 
infarction. Imaging is vital to 
the diagnosis and cardiovascular 
investigations are as essential as 
they are with any stroke patient. 
Treatment is based on the relief 
of symptoms, which can include 
a wide array of therapies from 
invasive to rehabilitative. The 
size and location of the lesion 
affects the prognosis, which may 
have transient to long-lasting 
neurological effects. Aeromedical 
considerations are based on 
recovery from neurological deficits 
that would negatively affect safe 
aviation.
History
a 
46-year-olD  male pilot applied 
for a second-class medical certi-
fication. During the year before 
requesting  certification,  he  visited  a 
hospital with the single complaint of 
vertigo. Magnetic resonance imaging 
(MRI) was accomplished but did not 
reveal any abnormal lesions. The next 
day, he went to another hospital with 
the same complaint, but now his symp-
toms included left facial numbness and 
swallowing disturbance. In addition to 
the numbness, he had sensation of heat 
on the left side of the face. He had no 
significant  medical  history  or  noted 
trauma.  On  physical  exam,  he  had 
nystagmus to the right and deviation 
of the uvula to the left. There was no 
deviation of his tongue. His left finger-
to-nose test was poor. His left-sided 
ataxia-induced gait disturbance made 
tandem  gait  testing  impossible.  His 
muscle strength was reported as normal. 
MRI showed a high intensity region, 
indicating a tiny infarct lesion in the 
dorsolateral aspect of the left medulla 
oblongata. Magnetic resonance angio-
gram showed a string-shaped stenosis 
of the region of the proximal portion 
of the left posterior inferior cerebellar 
artery (PICA) with the periphery of the 
left PICA fed by retrograde pooling from 
the anterior inferior cerebellar artery. 
He was diagnosed with Wallenberg’s 
syndrome. He was treated conserva-
tively and released 10 days later with 
ataxia  and  swallowing  disturbances 
fully recovered. Six months later, he 
had a normal otoneurologic exam and 
a follow-up MRI that was negative for 
new lesions. However, residual left facial 
numbness continued up until the time 
of medical certification application.
WALLenberG’s syndroMe
Wallenberg’s syndrome is a neu-
rological condition caused by a 
brain  stem  stroke.  This  is  also 
called lateral medullary infarction 
or  posterior  inferior  cerebellar 
artery infarction. It is due to a 
disruption  of  the  flow  blood 
through the vertebral or posterior 
inferior  cerebellar  artery.  This 
can by a thromboembolic event 
or the dissection of the artery 
through  aneurysm  or  trauma.2 
The symptoms that manifest are 
a result of where the disruption 
of blood flow occurs and can 
include:
Symptoms
  ■ Vestibulocerebellar  vertigo, 
difficulty  sitting/standing  due  to 
pulling sensation, tilting or swaying, 
hypotonia  of  the  upper  extremity, 
blurred  vision/diplopia,  nystagmus 
(very common, especially in patients 
complaining of vertigo), or limb ataxia 
(usually ipsilateral to the lesion). 
  ■ Sensory pain or unpleasant feel-
ing in the face (heat sensation), loss of 
pain and temperature in the contralat-
eral trunk/limbs due to spinothalamic 
tract damage, and decreased corneal 
reflex ipsilaterally.
  ■ Bulbar Muscle Weakness: af-
fecting nucleus ambiguous resulting 
in paralysis of ipsilateral plate, phar-
ynx,  and/or  larynx  manifesting  as 
dysphagia or dysphonia, contralateral 
uvula deviation.
  ■ Autonomic  Dysfunction: 
Horner’s  syndrome  ipsilaterally; 
cardiogenic effects to include tachy-
cardia, orthostatic hypertension, and/
or intermittent bardycardia.3,4
Diagnosis
Correlation of signs and symptoms 
with imaging studies.
Treatment
Relief of symptoms and rehabilita-
tion to recover function and/or deal 
with neurologic loss.
Prognosis
Dependant of the size and location 
of the area of the brain stem damaged 
by the stroke. It can be transient or 
it can be a neurological deficit that 
last years.2
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Aeromedical Issues
As with all pathophysiological condi-
tions, the primary aeromedical concern 
is the risk for incapacitation (sudden 
or subtle) during flight, creating an 
unsafe aviation environment. The air-
man’s continued neurological deficit is 
concerning in this particular case. Title 
14 of the Code of Federal Regulations, 
part 67, Item 46 (Neurologic) states, 
“Symptoms  or  disturbances  that  are 
secondary to the underlying condition 
and that may be acutely incapacitating 
include pain, weakness, vertigo or in 
coordination, seizures or a disturbance 
of consciousness, visual disturbance, or 
mental confusion.”1 
Although  this  airman’s  residual 
paresthesia might not be specifically 
included in the above statement, his 
persistent deficit could still be aeromedi-
cally  hazardous.  Non-incapacitating 
neurological  deficits  can  be  just  as 
dangerous in-flight if it is distracting 
from safe operation of the aircraft and 
needs to be considered. The AME Guide 
also  states,  “chronic  conditions  may 
be incompatible with safety in aircraft 
operation because of long-term unpre-
dictability, severe neurological deficit, 
or psychological impairment.”1 It is the 
unpredictability of this condition that 
requires a more extensive workup be 
accomplished  following  an  adequate 
recovery period. In most cases involving 
stroke, a two-year recovery period from 
neurologic deficits is required before 
consideration for an airman medical 
certificate.
A complete neurological evaluation 
must be provided at the end of this re-
covery period. Considerations are more 
likely to be in favor of the airman if the 
cause could be identified and success-
fully treated.
Outcome
The case was reviewed and issued 
a Final Denial due to transient loss of 
nervous  system  function  that  is  not 
resolved. Reconsideration may be given 
if current full neurologic and cardio-
vascular exams are provided two years 
from the time of incident.
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Form 8500-8 Phase-Out Deadline Approaching
•	Reduced filing—there is no require-
ment for the AME to keep a copy 
of the Form 8500-8 or the medical 
certificate information since it is kept 
in the Aerospace Medical Certifica-
tion Subsystem (AMCS).
•	Decreased  AME  errors—an  AME 
cannot inadvertently issue a certifi-
cate for an airman who may have a 
recent  exam  pending  or  have  an 
administrative  action  that  would 
preclude immediate issuance.
•	Increased  communication–  he 
communication between AME and 
airman is enhanced by the ability 
to discuss the airman’s case before a 
formal application is sent to the FAA. 
By Brian Pinkston, MD
a
s a remInDer, MedXPress will be 
mandatory for airmen to use after 
1 October 2012. Currently, more than 
43%  of  all  medical  applications  are 
being  conducted  using  MedXPress, 
and users are enjoying the ability to 
review their applications for medical 
certificates with their AMEs prior to 
the aviation medical examination visit. 
Using the summary page provided by 
MedXPress to the airman, the aviation 
medical examiner can let the airman 
know what type of information may be 
needed for the appointment in order to 
expedite medical certificate issuance.
MedXPress  provides  four  distinct 
advantages over the paper system:
•	Improved visibility–as soon as the 
application is imported into MedX-
Press, the FAA can see that an exam 
has started. This provides coverage 
for the airman on ramp checks, as 
opposed to the paper system. In the 
latter case, the AME could issue a cer-
tificate that may not be visible by the 
FAA until the AME has completed 
the exam in AMCS.
Further information for airmen is 
available in the online MedXPress bro-
chure, located at www.faa.gov/pilots/
safety/pilotsafetybrochures/media/
medxpress.pdf
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2012 Seminars
August 10–12 Washington, D.C. Neurology Theme (1)
August 23–26 Berlin, Germany EUSAM (2)
October 4–6 La Jolla, California CAMA (3)
October 29–November 2 Oklahoma City, Oklahoma Basic (4)
November 16–18 Denver, Colorado  Ophthalmology-Otolaryngology-Endocrinology Theme (1)
2013 Seminars
January 25–27 Tampa, Florida  Cardiology Theme (1)
February 25–March 1 Oklahoma City, Oklahoma Basic (4)
March 15–17 Dallas, Texas  Neurology Theme (1)
May 13–16 Chicago, Illinois  AsMA (5)
July 15–19 Oklahoma City, Oklahoma Basic (4)
August 9–11 Washington, D.C. Ophthalmology-Otolaryngology-Endocrinology Theme (1)
September 26–28 Orlando, Florida CAMA (3)
October 28–Nov. 1 Oklahoma City, Oklahoma Basic (4)
November 15–17 Sacramento, California Cardiology Theme TENTATIVE (1)
Aviation Medical Examiner Seminar Schedule
FAA Civil Aerospace Medical Institute
NOTES
(1)   A 2½-day theme aviation medical examiner (AME) seminar consisting of aviation medical examiner-specific subjects 
plus subjects related to a designated theme. Registration must be made through the Oklahoma City AME Programs 
staff, (405) 954-4831.
(2)  This seminar is sponsored by EUSAM, the European School of Aviation Medicine, and is sanctioned by the FAA as 
fulfilling the FAA and the JAA recertification training requirement. For more information and to register, see the 
EUSAM Web site: www.flugmed.org. Once there, click on EUSAM, then click on Refresher FAA/JAA (from the left 
menu).
(3)  This seminar is being sponsored by the Civil Aviation Medical Association (CAMA) and is sanctioned by the FAA as 
fulfilling the FAA recertification training requirement. Registration will be through the CAMA  
website: www.civilavmed.com.
(4)  A 4½-day basic AME seminar focused on preparing physicians to be designated as aviation medical examiners. Call 
your Regional Flight Surgeon.
(5)   A 3½-day theme AME seminar held in conjunction with the Aerospace Medical Association (AsMA). This seminar 
is a new Medical Certification theme, with 9 aeromedical certification lectures presented by FAA medical review 
officers, in addition to other medical specialty topics. Registration must be made through AsMA at (703) 739-2240. 
A registration fee will be charged by AsMA to cover their overhead costs. Registrants have full access to the AsMA 
meeting. CME credit for the FAA seminar is free.
The Civil Aerospace Medical Institute is accredited by the Accreditation Council for Continuing Medical Education  
to sponsor continuing medical education for physicians.